All AbMole products are for research use only, cannot be used for human consumption.
GB1107 is a potent, selective, orally active galectin-3 inhibitor with Kd of 37 nM. GB1107 inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade. GB1107 potentiates the effects of a PD-L1 immune checkpoint inhibitor to increase expression of cytotoxic (IFN-γ, granzyme B, perforin-1, Fas ligand) and apoptotic (cleaved caspase-3) effector molecules.
| Molecular Weight | 522.32 |
| Formula | C20H16Cl2F3N3O4S |
| CAS Number | 1978336-61-6 |
| Solubility (25°C) | DMSO 45 mg/mL |
| Storage | -20°C, dry, sealed |
| Related Galectin Products |
|---|
| Galectin-3 antagonist 1
Galectin-3 antagonist 1 is a potent and selective Galectin-3 (Gal-3) antagonist with Kd value of 5.3 μM. |
| Galectin-3/galectin-8-IN-2
Galectin-3/galectin-8-IN-2 is a dual Galectin-3 and galectin-8 C-terminal domain inhibitor, with Kd values of 12.8 μM and 2.06 μM respectively. |
| Galectin-3/galectin-8-IN-1
Galectin-3/galectin-8-IN-1 is a dual Galectin-3 and galectin-8 C-terminal domain inhibitor, with Kd values of 4.12 μM and 6.04 μM respectively. |
| Belapectin
Belapectin, a galectin 3 inhibitor with a Ki value of 2.8 μM, reduces hepatic fibrosis and portal hypertension in rats, and can be used in studies related to non-alcoholic steatohepatitis (NASH). |
| Selvigaltin
Selvigaltin (GB1211) is an orally available galectin-3 (Gal-3) inhibitor. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
